Vaxcyte, Inc. (PCVX)

Vaxcyte (PCVX) Balance Sheet


Vaxcyte Balance Sheet

Vaxcyte's total assets for Q1 2024 were $2.09B, an increase of 48.54% from the previous quarter. PCVX total liabilities were $107.32M for the fiscal quarter, a -35.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 1.41B$ 1.01B$ 324.34M$ 392.83M$ 65.70M
Total Liabilities
$ 167.45M$ 52.56M$ 40.32M$ 46.98M$ 172.07M
Total Equity Gross Minority
$ 1.24B$ 953.61M$ 284.02M$ 345.84M$ -106.37M
Total Capitalization
$ 1.26B$ 965.64M$ 284.02M$ 345.84M$ -106.37M
Preferred Stock Equity
Capital Lease Obligations
---$ 0.00$ 161.00K
Currency in USD

Vaxcyte Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis